| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 0 | 56.242 | 81.085 | 87.708 | 91.812 | 107.030 | 107.771 | 97.038 | 97.996 |
| Total Income - EUR | - | 0 | 56.245 | 81.093 | 87.715 | 91.819 | 107.039 | 107.782 | 101.162 | 102.093 |
| Total Expenses - EUR | - | 285 | 19.992 | 20.613 | 24.694 | 20.783 | 32.583 | 26.615 | 31.996 | 35.256 |
| Gross Profit/Loss - EUR | - | -285 | 36.253 | 60.480 | 63.021 | 71.036 | 74.457 | 81.167 | 69.166 | 66.837 |
| Net Profit/Loss - EUR | - | -285 | 35.691 | 59.669 | 62.142 | 70.508 | 73.710 | 80.111 | 68.175 | 63.836 |
| Employees | - | 1 | 2 | 1 | 2 | 3 | 3 | 2 | 2 | 2 |
Check the financial reports for the company - Ophtamedica Vision S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 146 | 2 | 0 | 0 | 0 | 0 | 0 | 20.474 | 17.198 |
| Current Assets | - | 65 | 36.844 | 61.017 | 64.206 | 72.988 | 75.001 | 142.175 | 91.001 | 118.670 |
| Inventories | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | 0 | 5.678 | 6.845 | 6.238 | 73 | 72 | 64.060 | 5.831 | 1 |
| Cash | - | 65 | 31.165 | 54.173 | 57.968 | 72.915 | 74.929 | 78.115 | 85.170 | 118.668 |
| Shareholders Funds | - | -240 | 35.454 | 59.437 | 62.185 | 70.550 | 73.751 | 80.151 | 68.215 | 63.876 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 451 | 1.392 | 1.580 | 2.021 | 2.438 | 1.250 | 62.024 | 43.260 | 71.992 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Ophtamedica Vision S.r.l.